Publications

October 11, 2022

ESGCT – 2022 – Poster Presentation P432

Platform

Multiplex deletion of myeloid antigens by base editing in human hematopoietic stem and progenitor cells (HSPCs) enables potential for next generation transplant for acute myeloid leukemia (AML) treatment